CNRS UMR8199 (directeur : Pr. Philippe Froguel)

CNRS UMR8199, under the direction of Pr. Philippe Froguel, is a leading biotechnology research institution dedicated to advancing the understanding and treatment of metabolic diseases. Focused on genomics and molecular physiology, CNRS UMR8199 aims to uncover the genetic causes of metabolic disorders, paving the way for more effective prevention and treatments. With a commitment to innovation and excellence, CNRS UMR8199 operates at the forefront of biotechnological research. The institute is located in Durham, US.

CNRS UMR8199's research encompasses a wide range of specialties, including diabetes and obesity, reflecting its dedication to addressing critical health challenges. Through rigorous scientific inquiry and collaborative efforts, CNRS UMR8199 strives to make significant contributions to the field of metabolic disease research. The team, led by Philippe Froguel, a DR at CNRS and Professor of Genomic Medicine at Imperial College London, brings together expertise from diverse disciplines to drive impactful discoveries.

CNRS UMR8199 continues to push the boundaries of biotechnology research, seeking to translate its findings into tangible benefits for individuals and communities affected by metabolic diseases. More comprehensive information about CNRS UMR8199 will be completed soon with the support of the company’s management. We invite the manager of CNRS UMR8199 to create a customized and exclusive company showcase and product listing on our platform.